Overview


According to FutureWise analysis the market for advanced infusion systems in 2023 is US$ 9.03 billion, and is expected to reach US$ 15.08 billion by 2031 at a CAGR of 6.60%.

External infusion pumps are indispensable in medical care, providing an exact and controlled mechanism for introducing fluids into a patient's body. These pumps are diverse, each tailored to meet specific medical needs in various healthcare settings and situations. These advanced devices can deliver fluids in precise quantities, making them essential for administering vital nutrients and crucial medications. They are versatile tools with unparalleled precision and accuracy, accommodating various treatments, including insulin, hormones, antibiotics, chemotherapy drugs, and pain relievers. Infusion pumps also exhibit versatility in their design and functionality. Some models are specifically designed for stationary use, seamlessly integrating into a patient's bedside setup, ensuring a steady and uninterrupted delivery of medications or nutrients.

Conversely, ambulatory infusion pumps offer portability and wearability, empowering patients to continue their daily activities while receiving necessary treatments. Specific types of infusion pumps have emerged within specialized medical care to cater to unique medical requirements. Enteral pumps, for example, specialize in delivering liquid nutrients and medications directly into a patient's digestive tract, ensuring optimal absorption. Patient-controlled analgesia (PCA) pumps enable patients to autonomously manage their pain by administering controlled doses of pain medication as needed, enhancing both comfort and independence. For individuals managing diabetes, insulin pumps provide a streamlined approach to insulin delivery, often allowing them to do so from the comfort of their homes. Developing advanced "smart pumps" significantly advances patient safety and healthcare. These intelligent devices incorporate safety features, such as alerts to notify users of potential adverse drug interactions or deviations from specified safety parameters. This proactive approach ensures patients receive treatments under the safest possible conditions, minimizing risks and promoting positive treatment outcomes.

FutureWise Market Research has published a report that provides an insightful analysis of Advanced Infusion Systems Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Advanced Infusion Systems Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Hospira, Inc.
  • AngioDynamics, Inc.
  • Animas Corporation
  • B. Braun Melsungen AG
  • Terumo Corporation
  • F. Hoffmann-La Roche Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

The increasing prevalence of chronic ailments such as diabetes and cardiovascular disease makes it necessary to use a precise drug delivery system, one of which is an advanced infusion system that drives market growth. With the growing aging population, there is increased aging illness that requires more advanced healthcare services, including infusion therapies, thus propelling the market. Technological advancement, on the other hand, is a boon to the healthcare sector, and the advancement incorporated in the drug administration, such as the innovations in the infusion systems, including the integration of intelligent features, making it more adaptable and easier to use and hence propelling the market growth. Furthermore, there are specific errors faced in medication. Advanced infusion system with enhanced features like barcoding scanning, dose calculations, and drug libraries aids in minimizing the mistakes related to the dose and administration, which improves patient safety and risk of adverse events, thus propelling the market growth.

However, certain restraints are affecting the market growth. The advanced infusion system requires proper maintenance, which initially costs high for installation and maintenance, which becomes a barrier to the market growth. Also, specialized training is needed to operate this advanced infusion system, which requires special training and trained professionals who can potentially use the same.

By Product Type

  • Elastomeric Infusion System
  • Volumetric Infusion System- Large Volume And Small Volume Pump
  • Patient Controlled Analgesia Pump
  • Disposable Infusion System
  • Syringe Infusion System
  • Ambulatory Infusion System
  • Implantable Infusion System

By Application Type

  • Chemotherapy
  • Diabetes
  • Pain Management
  • Asthma
  • Clinical Nutrition

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic centers
  • Bedside

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process. 

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America holds the largest share of the market due to the well-established health infrastructure, early adoption of technological advancements, and high healthcare expenditure. Whereas Asia-Pacific is a rapidly growing market due to the prevalence of chronic ailments, expanded access to healthcare services, and improvised healthcare infrastructure are driving the market growth in this region. In addition, government initiatives are playing a significant role in raising funds and promoting advanced healthcare technologies.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Advanced Infusion Systems Market By Product Type, By Application Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Advanced Infusion Systems Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Advanced Infusion Systems Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Advanced Infusion Systems Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Advanced Infusion Systems Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Elastomeric Infusion System
        2. Volumetric Infusion System- Large Volume And Small Volume Pump
        3. Patient Controlled Analgesia Pump
        4. Disposable Infusion System
        5. Syringe Infusion System
        6. Ambulatory Infusion System
        7. Implantable Infusion System

  • 8.   Advanced Infusion Systems Market, By Application Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Chemotherapy
        2. Diabetes
        3. Pain Management
        4. Asthma
        5. Clinical Nutrition

  • 9.   Advanced Infusion Systems Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Ambulatory Surgical Centers
        3. Diagnostic centers
        4. Bedside

  • 10.   North America Advanced Infusion Systems Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Advanced Infusion Systems Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Advanced Infusion Systems Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Advanced Infusion Systems Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Hospira, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. AngioDynamics, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Animas Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. B. Braun Melsungen AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Terumo Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. F. Hoffmann-La Roche Ltd.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients